Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cappai

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Brain Research|October 20, 1999
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout miceA R White, R Reyes, J F Mercer, et al.
Biochemistry|March 17, 1999
Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formationR Cappai, L Stewart, M F Jobling, et al.
The American Journal of Pathology|November 7, 1999
Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicityA R White, S J Collins, F Maher, et al.
Parasitology|May 1, 1994
Ricin-resistant mutants of Leishmania major which express modified lipophosphoglycan remain infective for miceR Cappai, L Morris, T Aebischer, et al.
FEBS Letters|November 14, 1997
Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's diseaseS S Mok, G Sberna, D Heffernan, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 1, 1998
Subcellular localization of the Alzheimer's disease amyloid precursor protein and derived polypeptides expressed in a recombinant yeast systemJ G Culvenor, A Henry, T Hartmann, et al.
Nature Structural Biology|April 14, 1999
Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor proteinJ Rossjohn, R Cappai, S C Feil, et al.
Journal of Neuroscience Research|September 11, 2001
Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126L R Stewart, A R White, M F Jobling, et al.
Neurobiology of Disease|April 13, 2001
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neuronsA R White, R Guirguis, M W Brazier, et al.
Journal of Neurochemistry|September 29, 1999
The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126M F Jobling, L R Stewart, A R White, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Brain Research|October 20, 1999
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout miceA R White, R Reyes, J F Mercer, et al.
Biochemistry|March 17, 1999
Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formationR Cappai, L Stewart, M F Jobling, et al.
The American Journal of Pathology|November 7, 1999
Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicityA R White, S J Collins, F Maher, et al.
Parasitology|May 1, 1994
Ricin-resistant mutants of Leishmania major which express modified lipophosphoglycan remain infective for miceR Cappai, L Morris, T Aebischer, et al.
FEBS Letters|November 14, 1997
Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's diseaseS S Mok, G Sberna, D Heffernan, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 1, 1998
Subcellular localization of the Alzheimer's disease amyloid precursor protein and derived polypeptides expressed in a recombinant yeast systemJ G Culvenor, A Henry, T Hartmann, et al.
Nature Structural Biology|April 14, 1999
Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor proteinJ Rossjohn, R Cappai, S C Feil, et al.
Journal of Neuroscience Research|September 11, 2001
Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126L R Stewart, A R White, M F Jobling, et al.
Neurobiology of Disease|April 13, 2001
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neuronsA R White, R Guirguis, M W Brazier, et al.
Journal of Neurochemistry|September 29, 1999
The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126M F Jobling, L R Stewart, A R White, et al.
Pageof 6